↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑Iwata-Reuyl D (2003). „Biosynthesis of the 7-deazaguanosine hypermodified nucleosides of transfer RNA”. Bioorg. Chem.31 (1): 24–43. DOI:10.1016/S0045-2068(02)00513-8. PMID12697167.
↑Morris RC, Elliott MS (2001). „Queuosine modification of tRNA: a case for convergent evolution”. Mol. Genet. Metab.74 (1–2): 147–159. DOI:10.1006/mgme.2001.3216. PMID11592812.
↑Harada F, Nishimura S (1972). „Possible anticodon sequences of tRNAHis, tRNAAsm, and tRNAAsp from Escherichia coli B. Universal presence of nucleoside Q in the first position of the anticondons of these transfer ribonucleic acids”. Biochemistry11 (2): 301–308. DOI:10.1021/bi00752a024. PMID4550561.
↑Bienz M and Kubli E (1981). „Wild-type tRNATyrG reads the TMV RNA stop codon, but Q base-modified tRNATyrQ does not”. Nature294 (5837): 188–190. DOI:10.1038/294188a0.
Florian Klepper, Eva-Maria Jahn, Volker Hickmann, Thomas Carell: „Synthese des tRNA-Nucleosids Queuosin unter Verwendung eines chiralen Allylazid-Intermediats“, Angewandte Chemie, 2007, 119 (13), pp. 2377–2379; DOI:10.1002/ange.200604579.
Florian Klepper, Eva-Maria Jahn, Volker Hickmann, Thomas Carell: „Synthesis of the Transfer-RNA Nucleoside Queuosine by Using a Chiral Allyl Azide Intermediate“, Angewandte Chemie International Edition, 2007, 46 (13), pp. 2325–2327; DOI:10.1002/anie.200604579.